Stock listing
Compass Therapeutics, Inc.
Selected listing: CMPX · NASDAQ · USD · US
Compass Therapeutics, Inc. (NASDAQ:CMPX), Health Technology. Latest release Sep 22, 2026: Compass Therapeutics Provides Regulatory Update on Tovecimig…
- Ticker
- NASDAQ:CMPX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Compass Therapeutics, Inc.
The company focuses on developing innovative therapies to address unmet medical needs. Compass Therapeutics is committed to advancing its research and development efforts in the biopharmaceutical sector.
Latest news from Compass Therapeutics, Inc.
Compass Therapeutics Provides Regulatory Update on Tovecimig in Biliary Tract Cancer Following FDA Feedback
September 22, 2026
Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update
August 6, 2026
Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026
July 17, 2026
Compass Therapeutics to Participate in Upcoming June Investor Events
May 28, 2026
Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting
May 21, 2026
Events
Replays
Compass Therapeutics, Inc. (CMPX) Q2 2025 Earnings Call
Mon, Aug 11, 2025 · 08:00 AM ET
Watch
Research Compass Therapeutics, Inc.
Compass Therapeutics, Inc. company profile
View the public company page for Compass Therapeutics, Inc. on 6ix.
Compass Therapeutics, Inc. news
Read company news and market updates connected to Compass Therapeutics, Inc..
Compass Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Compass Therapeutics, Inc..